VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+30.89%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
10 Year Return
AUM
$195M
AUM Growth
+$195M
Cap. Flow
-$2.54M
Cap. Flow %
-1.3%
Top 10 Hldgs %
80.78%
Holding
26
New
3
Increased
2
Reduced
2
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$42.7M 21.91% 1,035,657
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$1.74B
$25.2M 12.95% 5,721,142
PDSB icon
3
PDS Biotechnology
PDSB
$57.8M
$20.1M 10.33% 1,933,582
ASND icon
4
Ascendis Pharma
ASND
$11.8B
$14.5M 7.44% 721,152
CTMX icon
5
CytomX Therapeutics
CTMX
$336M
$9.06M 4.65% 577,831
BOLD
6
DELISTED
Audentes Therapeutics, Inc
BOLD
$7.27M 3.73% +458,882 New +$7.27M
HRTX icon
7
Heron Therapeutics
HRTX
$207M
$6.99M 3.59% 405,901
CLCD
8
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$6.07M 3.12% +159,110 New +$6.07M
SIOX
9
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.01M 3.09% 429,590
RGNX icon
10
Regenxbio
RGNX
$451M
$4.66M 2.39% 332,494 -667,139 -67% -$9.35M
ARCT icon
11
Arcturus Therapeutics
ARCT
$462M
$3.8M 1.95% 1,537,463 +83,061 +6% +$205K
ONC
12
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$3.67M 1.88% 119,000
CHRS icon
13
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$3.47M 1.78% 129,629 -129,630 -50% -$3.47M
STML
14
DELISTED
Stemline Therapeutics, Inc.
STML
$3.42M 1.76% 315,980
ACHN
15
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$3.4M 1.75% +420,000 New +$3.4M
AKTX
16
Akari Therapeutics
AKTX
$24.8M
$3.14M 1.61% 369,490
ORKA
17
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$3.05M 1.57% 1,078,932
OCRX
18
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.87M 1.47% 1,088,372 +140,000 +15% +$370K
SYRE icon
19
Spyre Therapeutics
SYRE
$996M
$2.24M 1.15% 350,133
LPCN icon
20
Lipocine
LPCN
$15.8M
$1.87M 0.96% 420,000
ADVM icon
21
Adverum Biotechnologies
ADVM
$64.6M
$1.15M 0.59% 280,000
LRMR icon
22
Larimar Therapeutics
LRMR
$310M
$468K 0.24% 141,479
SRRA
23
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$238K 0.12% 130,798
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
-170,312 Closed -$2.83M